Patient Navigation in Medically Underserved Areas study design: A trial with implications for efficacy, effect modification, and full continuum assessment

Contemporary Clinical Trials

Volumn 53, Issue , 2017, Pages 29-35

  Molina, Yamile ^a   Glassgow, Anne E ^a   Kim, Sage J ^a   Watson, Karriem S ^a   Darnell, Julie S ^b   Calhoun, Elizabeth A ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; BREAST CANCER; CANCER SCREENING; CHINA; FEMALE; FOLLOW UP; GEOGRAPHIC INFORMATION SYSTEM; HEALTH CARE PLANNING; HEALTH EDUCATION; HUMAN; INCOME; MAMMOGRAPHY; MEDICAID; MEDICAL EDUCATION; MEDICARE; NAVIGATOR STAFFING; OUTCOME ASSESSMENT; PATIENT CARE; PERSONNEL MANAGEMENT; POVERTY; PSYCHOSOCIAL CARE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESIDENTIAL AREA; SENSITIVITY ANALYSIS; BREAST TUMOR; COMMUNITY HOSPITAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; ILLINOIS; PATIENT SATISFACTION; PHYSICAL EXAMINATION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

BREAST NEOPLASMS; CHICAGO; EARLY DETECTION OF CANCER; FEMALE; HOSPITALS, COMMUNITY; HUMANS; MAMMOGRAPHY; MEDICALLY UNDERSERVED AREA; PATIENT NAVIGATION; PATIENT SATISFACTION; PHYSICAL EXAMINATION; TIME FACTORS;

EID: 85003946055     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2016.12.001     Document Type: Article

References (40)

1. [1] Ooi, S., Martinez, M., Li, C., Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res. Treat. 127:3 (2011), 729–738, 10.1007/s10549-010-1191-6.
2. [2] Jemal, A., Clegg, L., Ward, E., Ries, L., Wu, X., Jamison, P., et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 101:1 (2004), 3–27, 10.1002/cncr.20288.
3. [3] Freeman, H., Patient navigation: a community based strategy to reduce cancer disparities. J. Urban Health 83 (2006), 139–141.
4. [4] Freeman, H., Rodriguez, R., History and principles of patient navigation. Cancer 117 (2011), 3537–3540.
5. [5] Freund, K., Battaglia, T., Calhoun, E., Dudley, D., Fiscella, K., Paskett, E., et al. The NCI patient navigation research program methods, protocol, and measures. Cancer 113 (2008), 3391–3399.
6. [6] Markossian, T., Darnell, J., Calhoun, E., Follow-up and timeliness after abnormal cancer screening among underserved, urban women in a patient navigation program. Cancer Epidemiol. Biomark. Prev. 21 (2012), 1691–1700.
7. [7] Tejeda, S., Darnell, J., Cho, Y., Stolley, M., Markossian, T., Calhoun, E., Patient barriers to follow-up care for breast and cervical cancer abnormalities. J. Women's Health 22 (2013), 507–517.
8. [8] Ansell, D., Grabler, P., Whitman, S., Ferrans, C., Burgess-Bishop, J., Murray, L., et al. A community effort to reduce the black/white breast cancer mortality disparity in Chicago. Cancer Causes Control 20 (2009), 1681–1688.
9. [9] Hirschman, J., Whitman, S., Ansell, D., The black:white disparity in breast cancer mortality: the example of Chicago. Cancer Causes Control 18 (2007), 323–333.
10. [10] Hunt, B., Whitman, S., Hurlbert, M., Increasing black:white disparities in breast cancer mortality in the 50 largest cities in the United States. Cancer Epidemiol. 38 (2013), 118–123.
11. [11] Ko, N., Darnel, J., Calhoun, E., Freund, K., Wells, K., Shapiro, C., et al. Can patient navigation improve receipt of recommended breast cancer care? Evidence from the National Patient Research Program. J. Clin. Oncol. 32 (2014), 2758–2764.
12. [12] Paskett, E., Harrop, J., Wells, K., Patient navigation: an update on the state of science. CA Cancer J. Clin. 61 (2011), 237–249.
13. [13] Wells, K., Battaglia, T., Dudley, D., Garcia, R., Greene, A., Calhoun, E., et al. Patient navigation: state of the art or is science?. Cancer 113 (2008), 1999–2010.
14. [14] Robinson-White, S., Conroy, B., Slavish, K., Rosenzweig, M., Patient navigation in breast cancer: a systematic review. Cancer Nurs. 33 (2010), 127–140.
15. [15] Battaglia, T., Bak, S., Heeren, T., Chen, C., Kalish, R., Tringale, S., et al. Boston patient navigation research program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol. Biomark. Prev. 21 (2012), 1645–1654.
16. [16] Paskettt, E., Katz, M., Post, D., Pennell, M., Young, G., Seiber, J., et al. The Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests?. Cancer Epidemiol. Biomark. Prev. 21 (2012), 1620–1628.
17. [17] Raich, P., Whitley, E., Thorland, W., Valverde, P., Fiarclough, D., Program, D.P.N.R., Patient navigation improves cancer diagnostic resolution: an individually randomized clinical trial in an underserved population. Cancer Epidemiol. Biomark. Prev. 21 (2012), 1629–1638.
18. [18] Ferrante, J., Chen, P.-H., Kim, S., The effect of patient navigation on time to diagnosis, anxiety, and satisfaction in urban minority women with abnormal mammograms: a randomized controlled trial. J. Urban Health 85 (2007), 114–125.
19. [19] Ell, K., Vourlekis, B., Lee, P., Xie, B., Patient navigation and case management following an abnormal mammogram: a randomized clinical trial. Prev. Med. 44 (2007), 26–33.
20. [20] Maxwell, A., Jo, A., Crespi, C., Sudan, M., Bastani, R., Peer navigation improves diagnostic follow-up after breast cancer screening among Korean American women: results of a randomized trial. Cancer Causes Control 21 (2010), 1931–1940.
21. [21] Dignan, M., Burhansstipanov, L., Hariton, J., Harjo, L., Rattler, J., Lee, R., et al. A comparison of two Native American Navigator formats: face-to-face and telephone. Cancer Control 12 (2005), 28–33.
22. [22] Marshall, J., Mbah, O., Ford, J., Phelan-Emrick, D., Ahmed, S., Bone, L., et al. Effect of patient navigation on breast cancer screening among African American Medicare beneficiaries: a randomized controlled trial. J. Gen. Intern. Med. 31 (2016), 68–76.
23. [23] Hedlund, N., Risendal, B., Pauls, H., Valverde, P., Whitley, E., Esparaza, A., et al. Dissemination of patient navigation programs across the United States. J. Public Health Manag. Pract. 20 (2014), E15–E24.
24. [24] Warnecke, R., Oh, A., Breen, N., Gehlert, S., Paskett, E., Tucker, K., et al. Approaching health disparities from a population perspective: the National Institutes of Health Centers for Population Health and Health Disparities. Am. J. Public Health 98 (2008), 1608–1615.
25. [25] Barrett, R., Cho, Y., Weaver, K., Ryu, K., Campbell, R., Dolecek, T., et al. Neighborhood change and distant metastasis at diagnosis of breast cancer. Ann. Epidemiol. 18 (2008), 43–47.
26. [26] Zenk, S., Tarlov, E., Sun, J., Spatial equity in facilities providing low- or no-fee screening mammography in Chicago neighborhoods. J. Urban Health. 83 (2006), 195–210.
27. [27] Tarlov, E., Zenk, S., Campbell, R., Warnecke, R., Block, R., Characteristics of mammography facility locations and stage at breast cancer diagnosis in Chicago. J. Urban Health 86 (2009), 196–213.
28. [28] Miraftab, F.W.D., Salo, K., Cities and Inequalities in a Global and Neoliberal World. 2015, Routledge.
29. [29] USPSTF, Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann. Intern. Med. 151:10 (2009), 716–726.
30. [30] USPSTF, Screening for Breast Cancer: Topic Page. 2013.
31. [31] Martin, N., Wingfield, J., USPSTF, Screening recommendations for breast cancer: the potential impact on the African American community. J. Health Care Poor Underserved 23 (2012), 91–97.
32. [32] American Community survey 5 year estimates: 2007–2011. 2014.
33. [33] US Department of Health & Human Services, MUA Find. 2016 (Retrieved from: http://muafind.hrsa.gov).
34. [34] CDC, Behavioral Risk Factor Surveillance System 2014 Codebook. 2015.
35. [35] Shea, J., Macro, E., Dean, L., McMurphy, S., Schwartz, J., Armstrong, K., Development of a revised health care system distrust scale. J. Gen. Intern. Med. 23 (2008), 727–732.
36. [36] Powe, B., Fatalism among elderly African Americans: effects on colorectal cancer screening. Cancer Nurs. 18 (1995), 385–392.
37. [37] Wolf, M., Chang, C., Davis, T., Makoul, G., Development and validation of the communication and attitudinal self-efficacy scale for cancer (CASE-cancer). Patient Educ. Couns. 57 (2005), 333–341.
38. [38] DeGroff, A., Royalty, J., Howe, W., Buckman, D.W., Gardner, J., Poister, T., Hayes, N., When performance management works: a study of the National Breast and Cervical Cancer Early Detection Program. Cancer S16 (2014), 2566–2574.
39. [39] Comprehensive Cancer Network, National, NCCN Guidelines. 2016 (Retrieved from: https://www.nccn.org/framework/).
40. [40] Graham, J., Addin missing-data-relevant variables to FIML-based structural equation models. Struct. Equ. Model. 10 (2003), 80–100.